Table 1.
This study included the general characteristics of clinicopathological factors of patients with lung cancer.
| Factors | No. (%) of small cell lung cancer patients | No. (%) of lung adenocarcinoma patients | No. (%) of lung squamous carcinoma patients |
|---|---|---|---|
| Sex | |||
| Male | 164(64.00) | 269(57.98) | 390(90.00) |
| Female | 36(36.00) | 50(42.02) | 10(10.00) |
| Age (years) | |||
| ≤60 | 51(51.00) | 53(44.54) | 32(32.00) |
| >60 | 49(49.00) | 66(55.46) | 68(68.00) |
| Smoking | |||
| Positive | 445(45.00) | 545(37.82) | 664(64.00) |
| Negative | 55(55.00) | 74(62.18) | 36(36.00) |
| Alcohol | |||
| Positive | 31(31.00) | 22(18.49) | 34(34.00) |
| Negative | 69(69.00) | 97(81.51) | 66(66.00) |
| Differentiation type | |||
| Poorly differentiated | 100(100.00) | 24(20.17) | 51(51.00) |
| Moderately differentiated | 0(0.00) | 65(54.62) | 37(37.00) |
| Well differentiated | 0(0.00) | 30(25.21) | 12(12.00) |
| Lymph node metastasis | |||
| Positive | 47(47.00) | 45(37.82) | 34(34.00) |
| Negative | 53(53.00) | 74(62.18) | 66(66.00) |
| Clinical stages | |||
| I/II | 46(46.00) | 59(49.58) | 61(61.00) |
| III/IV | 54(54.00) | 60(50.42) | 39(39.00) |
1,2: χ2 =0.825, P=0.364; 2,3: χ2 =28.003, P<0.001; 1,3: χ2 =19.085, P<0.001.
4,5: χ2 =1.159, P=0.282; 5,6: χ2 =14.903, P<0.001; 4,6: χ2 =7.279, P=0.007.